James Anthony Martin - 12 Dec 2025 Form 4 Insider Report for Lumexa Imaging Holdings, Inc. (LMRI)

Reporting relationship: Chief Financial Officer
Issuer ticker: LMRI
Reported as of: 12 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jan 2026, 12:51:17 UTC
Prior SEC filing: 15 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Julie Szeker, attorney-in-fact

Key filing fact

James Anthony Martin filed Form 4 for Lumexa Imaging Holdings, Inc. (LMRI) on 15 Jan 2026.

Key facts

This page summarizes James Anthony Martin's Form 4 filing for Lumexa Imaging Holdings, Inc. (LMRI).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Jan 2026, 12:51.

Change

Previous filing in this sequence was filed on 15 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002105348 Primary reporting owner

Martin James Anthony

Relationship: Chief Financial Officer
Address: 4200 SIX FORKS ROAD, SUITE 1000, RALEIGH
Signature: /s/ Julie Szeker, attorney-in-fact
Signature date: 15 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMRI transaction

Common Stock

Award

Transaction value: $0
Shares: +27,027
Change %
Price: $0.000000
Shares after: 27,027
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1

LMRI transaction

Common Stock

Award

Transaction value: $0
Shares: +27,027
Change %: +100%
Price: $0.000000
Shares after: 54,054
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer.

Footnote F2

Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3]

Footnote F3

[continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date.

SEC remarks

This Form 4 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes, which delays we understand were due to the high volume of applications at the time.